Genprex, Inc. (GNPX): Price and Financial Metrics
GNPX Price/Volume Stats
| Current price | $2.15 | 52-week high | $14.80 |
| Prev. close | $2.25 | 52-week low | $0.28 |
| Day low | $2.00 | Volume | 4,075,900 |
| Day high | $2.59 | Avg. volume | 2,778,985 |
| 50-day MA | $0.82 | Dividend yield | N/A |
| 200-day MA | $2.55 | Market Cap | 5.57M |
GNPX Stock Price Chart Interactive Chart >
Genprex, Inc. (GNPX) Company Bio
Genprex, Inc., a clinical stage gene therapy company, develops drugs to treat cancer. Its lead product candidate is Oncoprex, an active anti-cancer agent that is in Phase II clinical trials for the treatment of non-small cell lung cancer (NSCLC). It also conducts preclinical research for developing Oncoprex to be administered with immunotherapies in NSCLC; and research into other tumor suppressor genes associated with chromosome. The company was founded in 2009 and is based in Austin, Texas.
GNPX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...